UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-1 and IFN-gamma differentially program human dendritic cells exposed to beta-glucan via IkappaB-zeta regulation (P6279)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.193-193.9

2013

Volltextzugriff (PDF)

[1]Benzothieno[3,2‑b]benzothiophene-Based Organic Dyes for Dye‑Sensitized Solar Cells

Journal of organic chemistry, 2016-04, Vol.81 (8), p.3235-3245

2016

Volltextzugriff (PDF)

1: Na+/H+ exchangers (NHEs)

PH Deregulation As the Eleventh Hallmark of Cancer, 2023

2023

Volltextzugriff (PDF)

11 β-Hydroxysteroid dehydrogenase expression in first trimester human trophoblasts

Molecular and cellular endocrinology, 1998-06, Vol.141 (1), p.13-20

1998

Volltextzugriff (PDF)

11Beta-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts

Molecular and cellular endocrinology, 1998-06, Vol.141 (1-2), p.13-20

1998

Volltextzugriff (PDF)

11β-Hydroxysteroid dehydrogenase expression in first trimester human trophoblasts

Molecular and cellular endocrinology, 1998-06, Vol.141 (1-2), p.13-20

1998

Volltextzugriff (PDF)

120-LB: Small Molecule Activator of Pyruvate Kinase Regulates In Vivo Glucose Homeostasis

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

121P - AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)

Annals of oncology, 2019-10, Vol.30, p.v37-v38

2019

Volltextzugriff (PDF)

121PAXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1221P The functional domain of BRCA1/2 pathogenic variants (PVs) as potential biomarkers of second tumor and domain-related sensitivity to PARP-inhibitors

Annals of oncology, 2023-10, Vol.34, p.S716-S716

2023

Volltextzugriff (PDF)

127-OR: In Vivo Genetic Evidence That the Pyruvate Kinase Isoforms PKM1 and PKM2 Differentially Control Beta-Cell Fuel Sensing

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

12P Individualized breast cancer therapy using Mcl-1 inhibition based combination

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

12P Individualized breast cancer therapy using Mcl-1 inhibition based combination

Annals of oncology, 2016-12, Vol.27, p.ix4-ix4

2016

Volltextzugriff (PDF)

156Magnetic resonance angiography imaging for neuro vascular bundles dosimetry after permanent prostate brachytherapy: A tool to prospectively improve the evaluation of the impact of dosimetry on erectile function

European urology supplements : official journal of the European Association of Urology, 2005-03, Vol.4 (3), p.42-42

2005

Volltextzugriff (PDF)

1579POPTIMAL STRATEGY WITH MULTI-TARGETED THERAPIES IN EGFR-DEPENDENT “QUADRUPLE WILD TYPE (WT) FOR KRAS, BRAF, NRAS AND PIK3CA GENES” COLORECTAL CANCER (CRC) XENOGRAFTS AFTER COMBINED TREATMENT OF IRINOTECAN PLUS CETUXIMAB

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv549-iv549

2014

Volltextzugriff (PDF)

1583PPRIMARY AND ACQUIRED RESISTANCE OF COLORECTAL CANCER CELLS TO ANTI-EGFR ANTIBODIES CAN BE OVERCOME BY THE TREATMENT WITH REGORAFENIB IN COMBINATION WITH CETUXIMAB

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv550-iv550

2014

Volltextzugriff (PDF)

1585PAXL TYROSINE KINASE RECEPTOR AS A KEY REGULATOR OF PROLIFERATION AND SURVIVAL IN COLORECTAL CANCER (CRC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv551-iv551

2014

Volltextzugriff (PDF)

1753P Universal DPYD genotyping in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy

Annals of oncology, 2023-10, Vol.34, p.S948-S949

2023

Volltextzugriff (PDF)

18PCombination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four consensus molecular subtypes

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1951P Niraparib and irinotecan combination in ATM-mutated colorectal cancer

Annals of oncology, 2020-09, Vol.31, p.S1099-S1100

2020

Volltextzugriff (PDF)

2: Voltage gated sodium channels (VGSCs)

PH Deregulation As the Eleventh Hallmark of Cancer, 2023

2023

Volltextzugriff (PDF)

20 nm N/sup +/ abrupt junction formation in strained Si/Si/sub 1-x/Ge/sub x/ MOS device

IEEE International Electron Devices Meeting 2003, 2003, p.20.1.1-20.1.4

2003

Volltextzugriff (PDF)

A.20 Preoperative screening and outpatient surgery are two ways to minimize hospital resource use: an Italian experience

British journal of anaesthesia : BJA, 1996-06, Vol.76, p.6

1996

Volltextzugriff (PDF)

209. Correction of Hunter Syndrome in the MPSII Mouse Model by AAV2/8-Mediated Gene Delivery

Molecular therapy, 2006-05, Vol.13 (S1), p.S81-S81

2006

Volltextzugriff (PDF)

215PEXPRESSION OF AXL RECEPTOR AND ITS LIGAND GAS6 IN COLORECTAL CANCER (CRC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv73-iv73

2014

Volltextzugriff (PDF)

1 – 25 von 3.128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.419)
Mit Volltextzugriff
(2.510)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

IL-1 and IFN-gamma differentially program human dendritic cells exposed to beta-glucan via IkappaB-zeta regulation (P6279)

[1]Benzothieno[3,2‑b]benzothiophene-Based Organic Dyes for Dye‑Sensitized Solar Cells

1: Na+/H+ exchangers (NHEs)

11 β-Hydroxysteroid dehydrogenase expression in first trimester human trophoblasts

11Beta-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts

11β-Hydroxysteroid dehydrogenase expression in first trimester human trophoblasts

120-LB: Small Molecule Activator of Pyruvate Kinase Regulates In Vivo Glucose Homeostasis

121P - AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)

121PAXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)

1221P The functional domain of BRCA1/2 pathogenic variants (PVs) as potential biomarkers of second tumor and domain-related sensitivity to PARP-inhibitors

127-OR: In Vivo Genetic Evidence That the Pyruvate Kinase Isoforms PKM1 and PKM2 Differentially Control Beta-Cell Fuel Sensing

12P Individualized breast cancer therapy using Mcl-1 inhibition based combination

12P Individualized breast cancer therapy using Mcl-1 inhibition based combination

156Magnetic resonance angiography imaging for neuro vascular bundles dosimetry after permanent prostate brachytherapy: A tool to prospectively improve the evaluation of the impact of dosimetry on erectile function

1579POPTIMAL STRATEGY WITH MULTI-TARGETED THERAPIES IN EGFR-DEPENDENT “QUADRUPLE WILD TYPE (WT) FOR KRAS, BRAF, NRAS AND PIK3CA GENES” COLORECTAL CANCER (CRC) XENOGRAFTS AFTER COMBINED TREATMENT OF IRINOTECAN PLUS CETUXIMAB

1583PPRIMARY AND ACQUIRED RESISTANCE OF COLORECTAL CANCER CELLS TO ANTI-EGFR ANTIBODIES CAN BE OVERCOME BY THE TREATMENT WITH REGORAFENIB IN COMBINATION WITH CETUXIMAB

1585PAXL TYROSINE KINASE RECEPTOR AS A KEY REGULATOR OF PROLIFERATION AND SURVIVAL IN COLORECTAL CANCER (CRC)

1753P Universal DPYD genotyping in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy

18PCombination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four consensus molecular subtypes

1951P Niraparib and irinotecan combination in ATM-mutated colorectal cancer

2: Voltage gated sodium channels (VGSCs)

20 nm N/sup +/ abrupt junction formation in strained Si/Si/sub 1-x/Ge/sub x/ MOS device

A.20 Preoperative screening and outpatient surgery are two ways to minimize hospital resource use: an Italian experience

209. Correction of Hunter Syndrome in the MPSII Mouse Model by AAV2/8-Mediated Gene Delivery

215PEXPRESSION OF AXL RECEPTOR AND ITS LIGAND GAS6 IN COLORECTAL CANCER (CRC)

Suchergebnisse filtern